CJC-1295 with DAC and HMG Interaction
CJC-1295 with DAC and HMG have an interaction requiring monitoring for interaction with 51% confidence. Both CJC-1295 with DAC and HMG can elevate estrogen. Combined estrogenic load increases risk of gynecomastia, water retention, and mood changes. Monitor estradiol levels and consider AI if needed. These compounds primarily affect different organ systems.
Compound Profiles
CJC-1295 with DAC
Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release
DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation..
View full profileHMG
Human Menopausal Gonadotropin | FSH/LH Fertility Hormone
HMG acts on gonadal tissue through two mechanisms: FSH stimulates growth and maturation of ovarian follicles containing eggs in women, and promotes spermatogenesis in men. LH stimulates ovulation and corpus luteum formation in women, and Leydig cells in men to produce testosterone.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take CJC-1295 with DAC with HMG?
Yes, but with caution. Both CJC-1295 with DAC and HMG can elevate estrogen. Combined estrogenic load increases risk of gynecomastia, water retention, and mood changes. Monitor estradiol levels and consider AI if needed. Regular monitoring is advised.
Is CJC-1295 with DAC and HMG safe together?
Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: estrogenic. Monitor accordingly.
What are the interactions between CJC-1295 with DAC and HMG?
Both CJC-1295 with DAC and HMG can elevate estrogen. Combined estrogenic load increases risk of gynecomastia, water retention, and mood changes. Monitor estradiol levels and consider AI if needed. This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.
How should I time CJC-1295 with DAC and HMG?
CJC-1295 with DAC has a half-life of 6-8 days and HMG has a half-life of ~32 hours (FSH component: 39-54 hours). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.